Resources
Cancer.net.
https://www.cancer.net/cancer-types/skin-cancer-non-melanoma
Cancer.org.
https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer.html
Skin Cancer Foundation.
https://www.skincancer.org/skin-cancer-information/squamous-cell-carcinoma/
Memorial Sloan Kettering Cancer Center. Cutaneous Squamous Cell Carcinoma.
https://www.mskcc.org/cancer-care/types/squamous-cell-carcinoma
American Academy of Dermatology. Skin Cancer Types. Cutaneous Squamous Cell Carcinoma. Overview.
https://www.aad.org/public/diseases/skin-cancer/types/common/scc
Treatment Recommendations
Work Group; Invited Reviewers, Kim JYS, et al. Guidelines of care for the management of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2018;78(3):560-578. https://pubmed.ncbi.nlm.nih.gov/29331386/
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Cutaneous Squamous Cell Carcinoma. https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/squamous.pdf
Stratigios A, Garbe C, Dessinioti C. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Eur J Cancer. 2020;128: 83-102. https://pubmed.ncbi.nlm.nih.gov/32113942/
Journal Articles
Bottomley MJ, Thomson J, Harwood C, Leigh I. The role of the immune system in cutaneous squamous cell carcinoma. Int J Mol Sci. 2019;20: 2009. doi:10.3390. https://pubmed.ncbi.nlm.nih.gov/31022866/
Dreyfuss I, Kamanth P, Frech F, et al. Squamous cell carcinoma: 2021 updated review of treatment. Dermatol Ther. 2022;35(4):e15308. https://pubmed.ncbi.nlm.nih.gov/34997811/Geidel G, Heidrich I, Kott J, et al. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma. NPJ Precis Oncol. 2022;6(1):17. https://pubmed.ncbi.nlm.nih.gov/35322182/
Gross N, Miller D, Khushalani N, et al. Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma. N Engl J Med. 2022;387(17):1557-1568. https://pubmed.ncbi.nlm.nih.gov/36094839/
Grob JJ, Gonzalez R, Basset-Seguin N, et al. Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: A single-arm phase II trial (KEYNOTE-629). J Clin Oncol. 2020;38: 2916-2925. https://pubmed.ncbi.nlm.nih.gov/32673170/
Migden MR, Rischin D, Schmults CD, et al. PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med. 2018;379: 341-351. https://pubmed.ncbi.nlm.nih.gov/29863979/
Migden MR, Chanda S, Rabinowits G, et al. CASE (CemiplimAb-rwlc Survivorship and Epidemiology) study in advanced cutaneous squamous cell carcinoma. Future Oncol. 2020;16: 11-19. https://www.futuremedicine.com/doi/pdf/10.2217/fon-2019-0762
Waldman A, Schmults C. Cutaneous squamous cell carcinoma. Hematol Oncol Clinic North Am. 2019;33: 1-12. https://pubmed.ncbi.nlm.nih.gov/30497667/
